Cell-mediated immune responses to MUC1 fusion protein coupled to mannan

Vaccine

Volumn 14, Issue 9, 1996, Pages 930-938

  Apostolopoulos, Vasso ^a   Pietersz, Geoffrey A ^a   McKenzie, Ian F C ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

Cancer; Cytotoxic T cells; Immunology; Mannan; MUC1; Mucin

Indexed keywords

CYCLOPHOSPHAMIDE; HYBRID PROTEIN; MANNAN; MUCIN;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030174878     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00258-3     Document Type: Article

References (41)

1. 1 Gendler, S., Papadimitriou, J.T., Duhig, T., Rothbard, J. and Burchell, J. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J. Biol. Chem. 1989, 263, 12820-12823
2. 2 Harisch, F.G. and Uhlenbruck, G. Structures of neutral O-Linked polylactosaminoglycans on human skim milk mucins. J. Biol. Chem. 1989, 264, 872-883
3. 3 Marjolijn, J.L., Lightenberg, M.J.L., Vos, H.L., Annemiek, M.C., Gennissen, A.M.C. and Hilkens, J. Episialin, a carcinoma-associated mucin is generated by a polymorphic gene encoding splice variants with alternating amino termini. J. Biol. Chem. 1990, 265, 5573-5578
4. 4 Cracker, G. and Price, M.R. Genetic polymorphism of high molecular weight glycoproteins: a comparative study in normal individuals and breast cancer patients. Br. J. Cancer 1987, 55, 651-652
5. 5 Apostolopoulos, V., Xing, P.X., Trapani, J.A. and McKenzie, I.F.C. Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein. Br. J. Cancer 1993, 67, 713-720
6. 6 Xing, P.X., Tjandra, J.J., Stacker, S.A. et al. Monoclonal antibodies reactive with mucin expressed in breast cancer. Immun. Cell Biol. 1989, 67, 183-185
7. 7 Xing, P.X., Prenzoska, J., Quelch, K. and McKenzie, I.F.C. Second generation anti-MUC1 peptide monoclonal antibodies. Cancer Res. 1992, 52, 2310-2317
8. 8 Xing, P.X., Tjandra, J.J., Reynolds. K., McLaughlin, P.J., Purcell, D.F.J. and McKenzie, I.F.C. Reactivity of anti-human milk fat globule antibodies with synthetic peptides. J. Immunol. 1989, 142, 3503-3509
9. 9 Xing, P.X., McKenzie, I.F.C. and Ceriani, R.L. Breast Epithelial Antigens. 1990, 45-54. Plenum Press, New York
10. 10 Barnd, D.L., Lan, M.S., Metzgar, R.S. and Finn, O.J. Specific, major histocompatibility complex - unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc. Natl Acad. Sci. USA 1989, 86, 7159-7163
11. 11 Jerome, K.R., Barnd, D.L., Boyer, C.M. et al. Adenocarcinoma reactive cytotoxic T lymphocytes recognize an epitope present on the protein core of epithelial mucin molecules. Cell. Immun. Immunother. Cancer 1990, 1990, 321-328
12. 12 Rughetti, A.,Turchi, V., Ghetti, C.A. et al. Human B-cell immune response to the polymorphic epithelial mucin. Cancer Res. 1993, 53, 2457-2459
13. 13 Kotera, Y., Fontenont, J.D., Pecher, G., Metzgar, R.S. and Finn, O.J. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic and colon cancer patients. Cancer Res. 1994, 54, 2856-2860
14. 14 Apostolopoulos, V., Xing, P.X. and McKenzie, I.F.C. Murine immune response to cells transfected with human MUC1 gene: immunization with cellular and synthetic antigens. Cancer Res. 1994, 54, 5186-5193
15. 15 Okawa, Y., Howard, C.R. and Steward, M.W. Production of anti-peptide antibody in mice following immunization with peptides conjugated to mannan. J. Immunol. Meth. 1992, 142, 127-131
16. 16 Siddiqui, J., Abe, M., Hayes, D., Shani, E., Yunis, E. and Kufe, D. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc. Natl Acad. Sci. USA 1988, 85, 2320-2323
17. 17 Smith, D.B. and Johnson, K.S. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988, 67, 31-40
18. 18 Zacharius, R.M., Zell, T.E., Morrison, J.H. and Woodlock, J.J. Glycoprotein staining following electrophoresis on acrylamide gels. Anal. Biochem. 1969, 30, 148-152
19. 19 Morrissey, J. Silver staining of acrylamide gels. Anal. Biochem. 1981, 117, 307-310
20. 20 Trapani, J.A., Browne, K.A., Dawson, M.J. et al. A novel gene constitutively expressed in human lymphoid cells is inducible with interferon-g in myeloid cells. Immunogenetics 1992, 36, 368-376
21. 21 Wreschner, D.H., Tsarfaty, I., Hareuveni, M., Rich, M.H., Hager, J.C. and Keydar, I. et al. Breast Cancer: Progress in Biology, Clinical Management and Prevention. 1989, 41-60. Kluwer Academic Publishers
22. 22 Wreschner, D.H., Hareuveni, M., Tsarfaty, I. et al. Human epithelial tumor antigen cDNA sequences: differential splicing may generate multiple protein forms. Eur. J. Biochem. 1990, 189, 463-473
23. 23 Acres, B., Hareuveni, M., Balloul, J.M. and Kieny, M.P. VV-MUC1 immunization of mice-immune response and protection against the growth of murine tumors bearing the MUC1 antigen. J. Immunother. 1993, 14, 136-143
24. 24 Tomonari, K. A rat antibody against a structure functionally related to the mouse T cell receptor/T3 complex. Immunogenetics 1988, 28, 455-458
25. 25 Pierres, A., Naquet, P. and VanAgthoven, A. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of la-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-la cytolytic T cell clones. J. Immunol. 1984, 132, 2775-2782
26. 26 Ledbetter, J.A. and Herzenberg, L.A. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immun. Rev. 1979, 47, 63-90
27. 27 Harlow, D., Lane, D., Harlow, E. and Lane, D. A Laboratory Manual. 1988, 271. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
28. 28 Hodges, R.S. and Merrifield, R.B. Monitoring of solid phase peptide synthesis by an automated spectrophotometric picrate method. Anal. Biochem. 1975, 65, 241-272
29. 29 Kent, S.B.H., Hood, L.E.A.N. and Izumiya. Peptides chemistry. 1984, 217-222. Osaka, Japan
30. 30 Domer, J.E., Garner, R.E. and Befidi-Mengue, R.N. Mannan as an antigen in cell-mediated immunity assays and as a modulator of mannan-specific CMI. Infect. Immun. 1989, 57, 693-700
31. 31 Ohta, M., Kido, N., Hasegawa, T. et al. Contribution of the mannan side-chains to the adjuvant action of lipopolysaccharides. Immunology 1987, 60, 503-507
32. 32 Warr, G.A. A macrophage receptor for (mannose/ glucosamine)-glycoproteins of potential importance in phagocytic activity. Biochem. Biophys. Res. Commun. 1980, 93, 737-744
33. 33 Tenu, J.P., Roch, A., Kieda, C., Monsigny, M. and Petit, J.F. Absence of cell surface receptors for muramyl peptides in mouse peritoneal macrophages. Biol. Cell. 1982, 44, 157-160
34. 2 immune responses. Proc. Natl Acad. Sci. USA 1995, 92, 10128-10132
35. 35 Rhodes, J. Erythrocyte Rosettes provide an analogue for schiff base formation specific T cell activation. J. Immunol. 1990, 145, 463-469
36. 36 Garner, R.E., Childress, A.M., Human, L.G. and Domer, J.F. Characterization of Candida albicans mannan-induced, mannan specific DTH suppressor cells. Infect. Immun. 1990, 58, 2613-2619
37. 37 Podzorski, R.P., Gray, G.R. and Nelson, R.D. Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro. J. Immunol. 1990, 144, 707-715
38. 38 Xing, P.X., Michaels, M., Apostolopoulos, V., Prenzoska, J., Bishop, J. and McKenzie, I.F.C. Phase I study of synthetic MUC1 peptides in cancer. Int. J. Oncol. 1995, 6, 1283-1289
39. 39 McLean, G.D., Bowen-Yacyshyn, M.D., Samuel, J. et al. Active immunisation of human ovarian cancer patients against a common carcinoma (TF) determinant using a synthetic carbohydrate antigen. J. Immunother. 1992, 11, 292-300
40. 40 McLean, G.D., Reddish, M., Koganty, R. et al. Immunization of breast cancer patients using a synthetic sialyl-Tn glyco-conjugate plus Detox adjuvant. Cancer Immun. Immunother. 1993, 36, 215-222
41. 41 Longenecker, B.M., Reddish, M., Koganty, R. and MacLean, G.D. Immune responses of mice and human breast cancer patients following immunisation with synthetic sialyl-Tn conjugated to KLH plus Detox adjuvant. In: Specific Immunotherapy of Cancer with Vaccines. Ann. NY Acad. Sci 1993, 690, 276-291